Trump considers drug rebate shake-up: 5 things to know

(By Alia Paavola for Becker’s Hospital Review)

The Trump administration is considering a proposal that will remove or alter safe harbor protections for pharmaceutical company rebates — a plan that could reshape how prescription drugs are priced and sold, according to The Wall Street Journal. Continue reading article here…


Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or

Leave a Reply